Quantum Genomics: Quantum Genomics publishes its results for the 2023 financial year. The merger with ExactCure, which marks the strategic redeployment of the company and will be submiCed for a shareholder vote on April 24.
Press Release Paris, March 13, 2024, 6 PM Quantum Genomics publishes its results for the 2023 financial year. The merger with ExactCure, which marks the
Read full article »
Quantum Genomics is a France-based biopharmaceutical company that develops and commercializes APA inhibitor drugs for the treatment of arterial hypertension and heart failure.
Read more